Clinical Trial Update: Study of rBet v1 Tablets [Phase 2]

View source ↗

Summary

A Phase 2 trial of rBet v1 tablets for birch pollen–related allergic conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• rBet v1 Tablets (recombinant Bet v 1)

Snippet

Sponsor: Stallergenes Greer | Conditions: Birch Pollen-related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED